Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
出版年份 2012 全文链接
标题
Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance
作者
关键词
-
出版物
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 114, Issue 1, Pages 21-34
出版商
Wiley
发表日期
2012-08-10
DOI
10.1002/jcb.24317
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- ALDH1-Bright Epithelial Ovarian Cancer Cells Are Associated with CD44 Expression, Drug Resistance, and Poor Clinical Outcome
- (2012) Yu-Chi Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- miR-297 modulates multidrug resistance in human colorectal carcinoma by down-regulating MRP-2
- (2012) Ke Xu et al. BIOCHEMICAL JOURNAL
- The Therapeutic Potential of MicroRNAs in Cancer
- (2012) Stine B. Thorsen et al. CANCER JOURNAL
- CD44+/CD24− ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival
- (2012) Erhong Meng et al. CLINICAL & EXPERIMENTAL METASTASIS
- MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17
- (2012) Ke Xu et al. EXPERIMENTAL CELL RESEARCH
- Ovarian cancer stem cells: elusive targets for chemotherapy
- (2012) Achuta Kumar Guddati MEDICAL ONCOLOGY
- Smoothened Antagonists Reverse Taxane Resistance in Ovarian Cancer
- (2012) A. D. Steg et al. MOLECULAR CANCER THERAPEUTICS
- Identification of a Potential Ovarian Cancer Stem Cell Gene Expression Profile from Advanced Stage Papillary Serous Ovarian Cancer
- (2012) Vinod Vathipadiekal et al. PLoS One
- Overcoming Challenges of Ovarian Cancer Stem Cells: Novel Therapeutic Approaches
- (2012) Cristóbal Aguilar-Gallardo et al. Stem Cell Reviews and Reports
- Clinical implications of REST and TUBB3 in ovarian cancer and its relationship to paclitaxel resistance
- (2012) Song Gao et al. TUMOR BIOLOGY
- Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells
- (2011) D Bose et al. BRITISH JOURNAL OF CANCER
- Molecular portraits of intratumoral heterogeneity in human ovarian cancer
- (2011) Yoon Pyo Choi et al. CANCER LETTERS
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway
- (2011) María Rosario García Campelo et al. Clinical & Translational Oncology
- Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome
- (2011) Lijing Luo et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2
- (2011) Qiuhua Wu et al. GYNECOLOGIC ONCOLOGY
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
- (2011) Ilona Kryczek et al. INTERNATIONAL JOURNAL OF CANCER
- Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile
- (2011) Ardian Latifi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2
- (2011) S. Rizzo et al. MOLECULAR CANCER THERAPEUTICS
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Specific Unsaturated Fatty Acids Enforce the Transdifferentiation of Human Cancer Cells toward Adipocyte-like Cells
- (2011) Antonio Ruiz-Vela et al. Stem Cell Reviews and Reports
- Clinical significance of side population in ovarian cancer cells
- (2011) Shinji Hosonuma et al. Human Cell
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Using aptamers to visualize and capture cancer cells
- (2010) Ying Pu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
- (2010) Nathan J Bowen et al. BMC Medical Genomics
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant
- (2010) L Hu et al. BRITISH JOURNAL OF CANCER
- Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells
- (2010) X. Yang et al. CANCER RESEARCH
- Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
- (2010) Diane Seimetz et al. CANCER TREATMENT REVIEWS
- EpCAM in carcinogenesis: the good, the bad or the ugly
- (2010) B. T. F. van der Gun et al. CARCINOGENESIS
- Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors
- (2010) Masaki Ieda et al. CELL
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside
- (2010) Jean-Emmanuel Kurtz et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer
- (2010) Michael et al. Frontiers in Bioscience-Landmark
- Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
- (2010) T. G. Oliver et al. GENES & DEVELOPMENT
- Excision repair cross-complementation group 1 protein overexpression as a predictor of poor survival for high-grade serous ovarian adenocarcinoma
- (2010) Stefanie Scheil-Bertram et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of imatinib mesylate (Gleevec®) and immunohistochemical expression of c-Kit and PDGFR-β in a Gynecologic Oncology Group Phase Il Trial in women with recurrent or persistent carcinosarcomas of the uterus
- (2010) Warner K. Huh et al. GYNECOLOGIC ONCOLOGY
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer
- (2010) Stefania Bellone et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Identification of MicroRNAs Regulating Reprogramming FactorLIN28in Embryonic Stem Cells and Cancer Cells
- (2010) Xiaomin Zhong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition
- (2010) Yvonne L Chao et al. Molecular Cancer
- Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
- (2010) C. N. Landen et al. MOLECULAR CANCER THERAPEUTICS
- Direct conversion of fibroblasts to functional neurons by defined factors
- (2010) Thomas Vierbuchen et al. NATURE
- Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer
- (2010) S Peng et al. ONCOGENE
- CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells
- (2010) M-Q Gao et al. ONCOGENE
- Microenvironment and Pathogenesis of Epithelial Ovarian Cancer
- (2010) Antonio F. Saad et al. Hormones & Cancer
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Ligand-based targeted therapy for cancer tissue
- (2009) Manasi Das et al. Expert Opinion on Drug Delivery
- Aptamers as inhibitors of target proteins
- (2009) S Missailidis et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer
- (2009) Ann K. Folkins et al. GYNECOLOGIC ONCOLOGY
- Human fallopian tube: a new source of multipotent adult mesenchymal stem cells discarded in surgical procedures
- (2009) Tatiana Jazedje et al. Journal of Translational Medicine
- Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
- (2009) K Levanon et al. ONCOGENE
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic and personalized medicine: foundations and applications
- (2009) Geoffrey S. Ginsburg et al. Translational Research
- Ovarian Cancer Pathogenesis: A Model in Evolution
- (2009) Alison M. Karst et al. Journal of Oncology
- G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation
- (2008) Keiji Tanese et al. AMERICAN JOURNAL OF PATHOLOGY
- CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers
- (2008) L M Smith et al. BRITISH JOURNAL OF CANCER
- Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial–mesenchymal transition in ovarian carcinomas
- (2008) M Colomiere et al. BRITISH JOURNAL OF CANCER
- Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis
- (2008) Daniela Matei et al. CANCER
- Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
- (2008) S. Zhang et al. CANCER RESEARCH
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
- Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes
- (2008) Irma Virant-Klun et al. DIFFERENTIATION
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
- (2008) Walter H. Gotlieb et al. GYNECOLOGIC ONCOLOGY
- MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
- (2008) Douglas D. Taylor et al. GYNECOLOGIC ONCOLOGY
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- Hyaluronan-CD44 Interaction Activates Stem Cell Marker Nanog, Stat-3-mediated MDR1 Gene Expression, and Ankyrin-regulated Multidrug Efflux in Breast and Ovarian Tumor Cells
- (2008) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects
- (2008) Christoph Mundhenke et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- “Stemness” Genomics Law Governs Clinical Behavior of Human Cancer: Implications for Decision Making in Disease Management
- (2008) Gennadi V. Glinsky JOURNAL OF CLINICAL ONCOLOGY
- Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
- (2008) Russell J. Schilder et al. JOURNAL OF CLINICAL ONCOLOGY
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of cells initiating human melanomas
- (2008) Tobias Schatton et al. NATURE
- Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
- (2008) T Baba et al. ONCOGENE
- Suppression of non-small cell lung tumor development by the let-7 microRNA family
- (2008) M. S. Kumar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics
- (2008) P. P. Szotek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Wnt signaling in ovarian tumorigenesis
- (2007) T.A. GATCLIFFE et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Expression of CD133-1 and CD133-2 in ovarian cancer
- (2007) G. FERRANDINA et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now